Clinical Trial Update: GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

View source ↗

Summary

A post-marketing surveillance trial of the GORE VIABAHN Endoprosthesis has completed (JPS 16-03) and results were posted in September 2024 for peripheral arteri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• GORE VIABAHN Endoprosthesis

Snippet

Sponsor: W.L.Gore & Associates | Conditions: Peripheral Arterial Disease | Status: COMPLETED | Results posted: 2024-09-20